Regulation & policy

Roadmaps to EU health claim success

Roadmaps to EU health claim success

By Shane Starling

As the European Union health claims climate evolves, companies are learning just what is required to demonstrate the benefits of healthy foods and supplements.

Provexis enjoys fruits of health claims victory

Dispatches from FIE

Provexis enjoys fruits of health claims victory

Provexis chief executive officer, Stephen Moon tells Shane Starling why becoming the first company to achieve an article 13.5 proprietary health claim has been such a boon to his company.

Life in a European health claims wasteland

Life in a European health claims wasteland

Ka-CHING! Hear that? No it’s not the sound of overflowing cash registers as consumers throw endless wads of euros at scientifically-backed, healthy foods in greater numbers than ever before.

Scientists attack proposed EU omega-3 DRVs

Scientists attack proposed EU omega-3 DRVs

By Shane Starling

An international consortium of concerned lipid scientists says the European Food Safety Authority (EFSA)-recommended omega-3 dietary reference values (DRVs) are seriously flawed and should be amended before they see the light of day in the European Union...

Scientists protest as EC validates omega-3 labelling rule

Scientists protest as EC validates omega-3 labelling rule

By Shane Starling

The group of international scientists that last week petitioned the European Commission to amend a mooted omega-3 labelling regulation they believe would confuse consumers, have vowed to continue their fight in the European Parliament, after the EC backed...

Bad day at the EU health claims office

Bad day at the EU health claims office

October 1 was not a good day for many in the functional foods and food supplements business in the European Union as the meaning of life under a highly restrictive health claims regime came more into focus.

Devil not so bad in EFSA health claim details

Devil not so bad in EFSA health claim details

By Shane Starling

At first glance yesterday’s publication of the first batch of 94 article 13.1 health claim opinions, is a worst-case scenario for industry, with claims for the likes of omega-3s, beta-glucan, folate, probiotics and taurine all drawing negative opinions...

EFSA says yes to third of first Article 13.1 claims

EFSA health claim opinion

EFSA says yes to third of first Article 13.1 claims

By Lorraine Heller

Around one third of the first batch of article 13.1 health claim applications have drawn positive opinions from EFSA. Professor Albert Flynn, the head of EFSA’s health claims assessment panel, tells NutraIngredients.com why some claims were favoured over...

Follow us

Products

View more

Webinars